Two Compartment Models | IV Bolus Kinetics Of Multiple Dosing | Unit 4 Biopharmaceutics 6th Semester
This video covers Unit 4 of Biopharmaceutics and Pharmacokinetics, focusing on the Two Compartment Open Model for IV Bolus administration. The instructor explains drug distribution between central and peripheral compartments, kinetic equations, and dosage regimen concepts including steady-state drug levels, loading dose, and maintenance dose.
Summary
The video is a lecture by Harshit Pandey covering Unit 4 of Biopharmaceutics and Pharmacokinetics, specifically the Two Compartment Open Model for IV Bolus administration. The instructor emphasizes that students must complete Unit 3 before attempting Unit 4, as foundational concepts are essential for understanding the material.
The Two Compartment Open Model is explained as consisting of a Central Compartment (blood and highly perfused organs like heart, liver, and kidneys) and a Peripheral Compartment (less perfused tissues like muscle and fat). When a drug is administered via IV bolus, it enters the central compartment first, then distributes reversibly to the peripheral compartment. Elimination occurs only from the central compartment, and drug movement follows first-order kinetics. The rate constants K12 (central to peripheral), K21 (peripheral to central), and K10 (elimination from central) are defined.
The instructor walks through the graphical representation of drug concentration over time in both compartments. At time zero, central compartment concentration is at maximum while peripheral is zero. As time progresses, rapid decline in central compartment occurs due to distribution to peripheral, followed by slower decline due to elimination. The peripheral compartment concentration first rises then falls as drug returns to central and is ultimately eliminated.
Mathematical equations are derived for the rate of change of drug concentration in both compartments (dCc/dt and dCp/dt), incorporating K12, K21, K10 terms. After substituting concentration with amount/volume of distribution, integrated equations are presented involving hybrid first-order constants alpha (α) and beta (β) representing distribution and elimination phases respectively. The relationships α + β = K12 + K21 + K10 and α·β = K21·K10 are also noted.
The dosage regimen section covers steady-state drug levels, loading dose, and maintenance dose. Steady-state is explained using a half-life example where repeated fixed dosing eventually results in the rate of administration equaling the rate of elimination, typically achieved after 4-5 half-lives. Loading dose is the initial higher dose given to rapidly achieve therapeutic plasma concentration, calculated as Css × Vd / F. Maintenance dose is the dose required to sustain steady-state concentration, dependent on drug clearance, dosing interval, and bioavailability. Clinical examples include emergency situations (seizures, arrhythmias) for loading doses and long-term conditions (hypertension, epilepsy) for maintenance doses.
Key Insights
- The instructor explains that in the Two Compartment Open Model, drug elimination occurs exclusively from the central compartment, not from the peripheral compartment, even though drug distributes reversibly between both compartments.
- The instructor describes that the initial rapid decline in central compartment drug concentration is due to distribution to the peripheral compartment, while the subsequent slower decline is due to elimination — these are represented by alpha and beta hybrid rate constants respectively.
- The instructor explains that steady-state drug concentration is achieved after approximately 4-5 half-lives of repeated fixed-dose administration, at which point the rate of drug administration equals the rate of drug elimination.
- The instructor argues that loading dose is an initial higher dose (e.g., double the maintenance dose) given to rapidly achieve therapeutic plasma concentration, particularly important in emergency situations like seizures or arrhythmias where delayed drug action could be harmful.
- The instructor states that drugs with low oral bioavailability require higher maintenance doses when given orally compared to IV administration, since only a small fraction of the oral dose reaches systemic circulation.
Topics
Full transcript available for MurmurCast members
Sign Up to Access